Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Shi, Ming  [Clear All Filters]
2013
Hu Z-L, Zhang X, Shi M, Tian Z-W, Huang Y, Chen J-Y, Ding Y-Q. Delayed but not loss of gliogenesis in Rbpj-deficient trigeminal ganglion. Int J Clin Exp Pathol. 2013;6(7):1261-71.
2016
Wei B, Sun X, Geng Z, Shi M, Chen Z, Chen L, Wang Y, Fu X. Isoproterenol regulates CD44 expression in gastric cancer cells through STAT3/MicroRNA373 cascade. Biomaterials. 2016;105:89-101.
2019
Wang Y, Qi K, Cheng H, Cao J, Shi M, Qiao J, Yan Z, Jing G, Pan B, Sang W, et al. Coagulation Disorders after CAR T Cell Therapy: Analysis of 100 Patients with R/R Hematologic Malignancies. Biol Blood Marrow Transplant. 2019.
Yin X, Hu L, Zhang Y, Zhu C, Cheng H, Xie X, Shi M, Zhu P, Zhao X, Chen W, et al. PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice. Bone Marrow Transplant. 2019.
Shi M, Xuan L, Zhang Y, Wang D, Ye F, Shi X, Li Y. Synergistic effects of thermal treatment and encapsulation of calcium phosphate nanoparticles on enhancing dimensional stability and osteogenic induction potential of free-standing PLGA electrospun membranes. Colloids Surf B Biointerfaces. 2019;183:110437.
2020
Li H, Yin L, Wang Y, Wang X, Shi M, Cao J, Yan Z, Sang W, Cheng H, Zhu F, et al. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment. Bone Marrow Transplant. 2020.
2021
Yuan X, Yuan W, Ding L, Shi M, Luo L, Wan Y, Oh J, Zhou Y, Bian L, Deng DYB. Cell-adaptable dynamic hydrogel reinforced with stem cells improves the functional repair of spinal cord injury by alleviating neuroinflammation. Biomaterials. 2021;279:121190.
Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu J-L, et al. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2021;75:103789.
Shi M, Li Y-Y, Xu R-N, Meng F-P, Yu S-J, Fu J-L, Hu J-H, Li J-X, Wang L-F, Jin L, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatol Int. 2021.
2022
Shi M, Xu Q, Ding L, Xia Y, Zhang C, Lai H, Liu C, Deng DYB. Cell Infiltrative Inner Connected Porous Hydrogel Improves Neural Stem Cell Migration and Differentiation for Functional Repair of Spinal Cord Injury. ACS Biomater Sci Eng. 2022.
2023
Liu Y, Jie X, Nian L, Wang Y, Wang C, Ma J, Jiang J, Wu Q, Qiao J, Chen W, et al. A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells. Front Immunol. 2023;14:1169071.
Li T-T, Zhang B, Fang H, Shi M, Yao W-Q, Li Y, Zhang C, Song J, Huang L, Xu Z, et al. Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2023;92:104600.
Zhang Q, Shi R, Hao M, Feng D, Wu R, Shi M. NDRG2 regulates the formation of reactive astrocyte-derived progenitor cells Notch signaling pathway after brain traumatic injury in rats. Front Mol Neurosci. 2023;16:1149683.
Ding L, Chu W, Xia Y, Shi M, Li T, Zhou F-Q, Deng DYB. UCHL1 facilitates protein aggregates clearance to enhance neural stem cell activation in spinal cord injury. Cell Death Dis. 2023;14(7):479.
2024
Shi M, Wang J, Huang H, Liu D, Cheng H, Wang X, Chen W, Yan Z, Sang W, Qi K, et al. Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nat Commun. 2024;15(1):3371.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, et al. Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy. Cytotherapy. 2024.